Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-068872
Filing Date
2014-11-14
Accepted
2014-11-14 16:39:03
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v394057_10q.htm 10-Q 288939
2 EXHIBIT 31.1 v394057_ex31-1.htm EX-31.1 11828
3 EXHIBIT 31.2 v394057_ex31-2.htm EX-31.2 12189
4 EXHIBIT 32.1 v394057_ex32-1.htm EX-32.1 5474
5 EXHIBIT 32.2 v394057_ex32-2.htm EX-32.2 5383
  Complete submission text file 0001144204-14-068872.txt   4297818

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tlcc-20140930_cal.xml EX-101.CAL 37395
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlcc-20140930_def.xml EX-101.DEF 205894
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlcc-20140930_lab.xml EX-101.LAB 256175
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlcc-20140930_pre.xml EX-101.PRE 244495
10 XBRL INSTANCE DOCUMENT tlcc-20140930.xml EX-101.INS 689042
11 XBRL TAXONOMY EXTENSION SCHEMA tlcc-20140930.xsd EX-101.SCH 33421
Mailing Address 632 BROADWAY SUITE 201 NEW YORK NY 10012
Business Address 632 BROADWAY SUITE 201 NEW YORK NY 10012 (212) 651-8500
TWINLAB CONSOLIDATED HOLDINGS, INC. (Filer) CIK: 0001590695 (see all company filings)

EIN.: 463951742 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55181 | Film No.: 141224896
SIC: 2833 Medicinal Chemicals & Botanical Products